Clinical Trial Update: Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study [Phase 3]

View source ↗

Summary

The Phase 3 CURE-AF trial evaluating concomitant radiofrequency energy for atrial fibrillation has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2013-10-16